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S U M M A R Y
Mucormycosis is a fungal infection commonly affecting structures in the head and neck, such as the air
sinuses, orbits, and the brain. Common predisposing factors include diabetes mellitus and
immunosuppression. We describe our clinical experience with four cases of mucormycosis of the
maxillary antrum associated with uncontrolled diabetes mellitus managed at our centre. Early diagnosis
and prompt treatment can signiﬁcantly reduce the mortality and morbidity of this lethal fungal
infection.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Mucormycosis is the common name given to several different
diseases caused by fungi of the order Mucorales.1 The patient
generally has uncontrolled diabetes mellitus and is acidotic, has a
hematological malignant disease like leukemia, or is receiving
immunosuppressive therapy.2,3 Usually mucormycosis presents as
an acute infection and manifests in rhinocerebral, pulmonary,
gastrointestinal, cutaneous, or disseminated forms,4 rarely affect-
ing otherwise healthy people.5 The infection begins in the upper
turbinate or paranasal sinuses,6,7 or less commonly in the palate or
pharynx. The most common presentation in the head and neck
region is maxillary and orbital cellulitis in a person with
inadequately controlled diabetes mellitus.7,8 Since mucormycosis
occurs infrequently, it may pose a diagnostic and therapeutic
dilemma for those who are not familiar with its clinical
presentations.
We describe our clinical experience with four cases of
mucormycosis of the maxillary antrum associated with uncon-
trolled diabetes mellitusmanaged at our centre. The series of cases
was reported with the following aims: (1) to draw attention to the
clinical presentation of mucormycosis; (2) to emphasize the need
for early diagnosis and prompt and aggressive surgical manage-
ment, followed by institution of speciﬁc antifungal chemotherapy
to ensure a favorable outcome; (3) to create awareness that a high
index of suspicion should be kept inmind in immunocompromised* Corresponding author. Tel.: +91 9412659813.
E-mail address: sideyedoc@yahoo.com (A. Pandey).
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doi:10.1016/j.ijid.2010.09.003patients presenting with exposed bone not responding to
antibiotic therapy.
2. Case reports
2.1. Case patient 1
A 65-year-old female patient reported to the maxillofacial
department with exposed bone and halitosis of 1-month duration.
The patient’s medical history showed diabetes mellitus under
improper treatment. She had been on oral hypoglycemic treatment
for the past 10 years, however over the last 3 years, due to ﬁnancial
constraints, the patient had taken herself off and on treatment
without consulting a physician or undergoing routine blood sugar
estimation. The patient gave a history of dental extraction of the
upper posterior tooth 4–5 months previously, due to swelling and
mobility. Following the extraction the socket had not healed
completely. On extra-oral examination there was mild swelling
over the cheek region. An intra-oral examination revealed exposed
necrotic gray-colored bone in the right maxillary molar region
(Figure 1). There was diffuse swelling on the palatal surface of the
maxilla.Maxillarymolarsweremissing and on palpation therewas
mobility of the exposed bone segment. A radiograph (paranasal
sinus view) was advised, which showed haziness of the maxillary
sinus with erosion of the lateral sinus wall. A computed
tomography (CT) scan showed radio-opaque maxillary antrum
and posterior wall destruction (Figure 2). Biochemical investiga-
tion revealed an elevated fasting blood sugar level of 230 mg/dl
and elevated post-prandial blood sugar level of 356 mg/dl. Ases. Published by Elsevier Ltd. All rights reserved.
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Figure 1. Intra-oral photograph showing necrosis of left maxillary alveolar bone.
[(Figure_3)TD$FIG]
Figure 3. H&E section reveals numerous fungal hyphae which are aseptate, broad
with obtuse angle branching, and without spore formation (40).
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of the hard tissue alongwith adjacent soft tissuewas excised under
local anesthesia and sent for microbiological and histopathological
examination. Microbiological examination revealed broad, asep-
tate, ribbon-like hyphae, and this was later conﬁrmed by culture.
Histopathological examination with hematoxylin and eosin (H&E)
stain readily identiﬁed non-septate mucormycotic hyphae
(Figure 3). Following conﬁrmation of the diagnosis within 4–5
days, the patient was hospitalized and her blood sugar was
controlled by the physician. On surgical exploration the necrotic
bone piece was found to be loose and was removed, leading to
opening of the antrum. On examination, the antral lining was
found to be thick and ﬁbrous. Maxillary sequestrectomy, total
antral curettage, and complete debridement were carried out, and
the wound was secondarily closed using an iodoform pack. An
incisional biopsy was taken from the maxillary alveolar ridge. The
patient was administered a single daily dose of liposomal
amphotericin B 1 mg/kg body weight as an infusion in 100 ml of
5% dextrose over 1–2 h for a period of 15 days. The blood urea and
creatinine levels were monitored for nephrotoxicity. The patient
was sent home on day 4 with advice to take injections and to come
for regular follow-up. Twoweeks later signs of healthy granulation
tissue were seen and the wound healed uneventfully in around 3
months.
2.2. Case patient 2
A 70-year-old male patient with a medical history of diabetes
mellitus and a history of renal dialysis, reported to the maxillofa-
cial department complaining of an intra-oral unhealed wound and
exposed bone of 1-week duration (Table 1). His previous dental
[(Figure_2)TD$FIG]Figure 2. A computed tomography scan showing shistory was suggestive of an alcohol block to the infraorbital nerve
for trigeminal neuralgia 5 months ago (suggestive of chemical
injury). Intra-oral examination revealed exposed necrotic gray-
colored bone in the maxillary molar region, with surrounding
necrotic tissue. X-ray of the paranasal sinuses and a CT scan
showed typical maxillary sinus opaciﬁcation with sinus wall
destruction. Excisional biopsy and culture of the tissue was
suggestive of mucormycosis of the maxilla. The patient was
admitted, his blood sugar level was managed by the physician, and
local debridement was done under general anesthesia. Following
surgery the patientwas started on oral ketoconazole for 3weeks. In
this case amphotericin Bwas not considered due to nephrotoxicity.
Signs of healthy granulation tissuewere seen after 3weeks and the
wound healed uneventfully in about 3 months.
2.3. Case patient 3
A 62-year-old female patient with a medical history of
uncontrolled diabetes mellitus for the past 12 years, reported to
our maxillofacial department with complaints of bad breath,
exposed bone, and pus discharge from the upper left jaw of 1-
month duration. She gave a history of self-extraction of a tooth. On
intra-oral examination, gray-colored exposed bonewas seen in the
buccal aspect of the maxilla and mobility of the dento-alveolar
segment was observed. A CT scan revealed maxillary sinus
opaciﬁcation with posterior wall destruction, provisionally sug-inus opaciﬁcation and sinus wall destruction.
Table 1
Summary of the clinical proﬁle of cases
Case
number
Presenting symptoms Age/sex Medical history/ trauma Surgical treatment Antifungal
therapy
Outcome
1 Intra-oral exposed bone,
foul breath
65 y/F Uncontrolled diabetes
mellitus; self-extraction
Maxillary sequestrectomy,
total antral curettage and
complete debridement
Liposomal
amphotericin B
Satisfactory on
follow-up to 24
months
2 Intra-oral unhealed wound
and exposed bone
70 y/ M Uncontrolled diabetes
mellitus on renal dialysis;
chemical injury
Local debridement Ketoconazole Satisfactory on
follow-up to 18
months
3 Bad breath, exposed bone and
pus discharge
62 y/F Uncontrolled diabetes
mellitus; self-extraction
Extraction of upper teeth,
sequestrectomy and
debridement of maxillary antrum
Liposomal
amphotericin B
Satisfactory on
follow-up to 24
months
4 Intra-oral exposed bone/foul
discharge
42 y/F Uncontrolled diabetes
mellitus/self-extraction
Complete debridement of maxillary
antrum through Caldwell–Luc
procedure; inferior meatus
antrostomy and buccal
advancement ﬂap for
closure of oro-antral ﬁstula
Liposomal
amphotericin B
Satisfactory on
follow-up to 16
months
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examinationwas compatiblewithmucormycosis. Extraction of the
upper teeth, sequestrectomy, and debridement of the maxillary
antrum was done. Intravenous amphotericin B was considered in
the post-operative phase (as for case patient 1) and the patient was
monitored for nephrotoxicity. Follow-up of the patient was
satisfactory.
2.4. Case patient 4
A 42-year-old female patient with uncontrolled diabetes
mellitus complained of foul discharge and exposed bone in the
upper jaw of 2-month duration. The patient was also complaining
of slow progressive swelling over the left upper jaw, which she
noticed approximately 2 months ago. The patient gave a history of
self-extraction of a tooth 2.5 months back. On intra-oral
examination, an infected socket wound and exposed dento-
alveolar segment and oro-antral communication was seen. Pus
from the antrum was sent for culture and was suggestive of
mucormycosis. The patient was admitted to the hospital and her
diabetes was controlled under the supervision of a physician.
Complete debridement of themaxillary antrum through Caldwell–
Luc procedure was done. An inferior meatus antrostomy and
buccal advancement ﬂap for closure of the oro-antral ﬁstula was
done under general anesthesia. Granulation tissue obtained from
the maxillary antrum was sent for histopathological examination
and was suggestive of mucormycosis. Intravenous amphotericin B
was given post-operatively. Follow-up of the patient was
satisfactory.
3. Discussion
Rhinocerebral mucormycosis is one of the most rapidly
progressing and lethal forms of fungal infection in humans and
usually begins in the nose and paranasal sinuses.4 In diabetic
patients there is a high incidence of mucormycosis caused by
Rhizopus arrhizus, because they produce the enzyme ketoreduc-
tase, which allows them to utilize the patient’s ketone bodies.7 All
our patients had uncontrolled diabetes mellitus, a common
predisposing factor, and we could grow Rhizopus species from
all of these cases.
In routine maxillofacial practice, intra-oral exposed bone
(maxillary necrosis) is generally diagnosed as osteomyelitis.
Maxillary necrosis can occur due to bacterial osteomyelitis,
herpes zoster, trauma, iatrogenic infections, or fungal infections,
such as mucormycosis, aspergillosis, etc. In our series of cases
we came across exposed bone, clinically mimicking bacterial
osteomyelitis, but leading to a different picture on microbiolog-ical and histopathological examination. All our patients gave a
history of previous trauma due to self-extraction of a tooth or
injection.
Radiologically, radio-opaque concretions may be identiﬁed in
aspergillosis, whereas mucormycosis shows opaciﬁcation of the
sinus.9 Therefore, a clinical suspicion of mucormycosis requires
conﬁrmation by radiological examination, preferably a CT scan of
the maxilla and orbit, showing membrane or periosteal thickening
and bony disruption,5 similar ﬁndings to those observed in our
cases. With regard to radiological examination, although magnetic
resonance imaging (MRI) is presumed to be a better diagnostic tool
for many clinical conditions, for fungal infection of the head and
neck region and for visualizing bone destruction (bony changes) a
CT scan is considered better than MRI.10 Moreover the cost-
effectiveness of CT scans as compared to MRI is also an important
factor.
As reported by Marx et al., if a patient is diabetic, a full workup
of serum glucose, electrolytes, blood chemistries, and blood gases
is required.8
Mucormycosis is a life-threatening disease and medical
management alone is not effective because of poor drug delivery
to the infection site due to extensive vascular thrombosis.11 The
ultimate outcome of mucormycosis depends in large part on the
prognosis of the underlying disease and the ability to reverse the
predisposing condition.1 The overall mortality rate has been
shown to be 50%, although higher survival rates of up to 80–85%
have recently been reported.12–14 The associated prognostic
factor depends on the extent of disease, including orbital or
intracranial extension in cases of rhinocerebral mucormycosis.
Aggressive correction of hyperglycemia and acidemia, followed
by resection-type debridement is needed. The general approach is
to diagnose early and to treat early and aggressively with all
modalities available. In our cases, treatment was planned
following diagnosis. The patients were referred to a physician
for management of the diabetes mellitus. It is quite possible that
our patients survived because of a strong clinical suspicion, early
diagnosis, and prompt and aggressive surgical treatment,
followed by speciﬁc antifungal chemotherapy. There was no
mortality in our cases and the clinical outcomewas satisfactory on
follow-up for a period of up to 24months. The currentmortality is
not great due to better diagnosis andmanagement of the usual co-
morbidities. As shown in various studies, the control of underlying
predisposing illness and aggressive surgical debridement, along
with prompt parenteral administration of amphotericin B
remains the essential treatment today.15–17
Though amphotericin B formulations have remained the
mainstay of treatment for mucormycosis, recent studies have
demonstrated that posaconazole, an extended-spectrum triazole
A. Pandey et al. / International Journal of Infectious Diseases 15 (2011) e66–e69 e69agent, has in vitro activity against zygomycetes and may represent
a therapeutic option for patients with serious invasive fungal
infections.18,19 A few microbiological studies have conﬁrmed in
vitro activity comparable to amphotericin B against Rhizopus and
Mucor.8,20 A study by Gonza´lez-Ramos et al. showing resolution of
cerebral infection in one of their cases (as evidenced by MRI) after
conservativemanagementwith posaconazolewithout the need for
neurosurgical intervention, supports its role in the management of
rhinocerebral involvement. These ﬁndings show posaconazole to
be an attractive alternative in patients intolerant to amphotericin B
or in whom its use is limited by nephrotoxicity.18 However clinical
data on the use of this medication for mucormycosis are limited.
Posaconazole could not be used for treatment in our cases as the
drug is not available in India.
To conclude, a diabetic patient with exposed necrotic bone and
a history of tooth extraction should alert the clinician to a possible
mucormycotic infection. Prompt and aggressive treatment is
required to ensure a favorable outcome.
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